The AJMC® Asthma compendium is a comprehensive resource for clinical news and expert insights for the chronic lung disease.
July 3rd 2025
Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being reviewed by the FDA.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists
Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies